King Steven R.'s Form 4 filing
Jaguar Health, Inc. (JAGX) · filed Apr 2, 2025
- Accession no.
- 0000950170-25-049808
- Filed
- Apr 2, 2025
- Trade date
- Mar 31, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| King Steven R.CIK 0001622052 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | Common Stock | PPurchaseAcquired | +3,600 | $20,000.00 | +$72,000,000 | 3,600 | Direct | Price outlier |
| Mar 31, 2025 | Common Stock | PPurchaseAcquired | +3,600 | –F2 | – | 3,600 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
As an inducement to enter into the Purchase Agreement, the reporting person received a warrant (the "Warrant") to purchase up to 3,600 shares of Common Stock with an exercise price of $5.43 per share. The Warrant is exercisable immediately upon issuance and will expire on the earlier of (i) five years from the date of issuance, (ii) the consummation of a fundamental transaction and (iii) the consummation of a liquidation event.
Referenced by the price of 1 transaction in Table II.
Remarks
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property and Secretary